Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease

Female sex is associated with a higher risk for autoimmune diseases (ADs) and immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs). While the safety of ICIs in AD cohorts has been reported, sex-segregated data on patient characteristics and outcomes are lacking. In the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Michael, Christ, Lisa, Richters, Anke, Özdemir, Berna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407854/
https://www.ncbi.nlm.nih.gov/pubmed/37559593
http://dx.doi.org/10.3892/ol.2023.13963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407854/
https://www.ncbi.nlm.nih.gov/pubmed/37559593
http://dx.doi.org/10.3892/ol.2023.13963

Ejemplares similares